Affordable Access

Erythropoietic growth factors for treatment-induced anemia in hepatitis C: a cost-effectiveness analysis.

Authors
  • Spiegel, Brennan M R
  • Chen, Kristina
  • Chiou, Chiun-Fang
  • Robbins, Sean
  • Younossi, Zobair M
Type
Published Article
Journal
Clinical Gastroenterology and Hepatology
Publisher
Elsevier
Publication Date
Oct 01, 2005
Volume
3
Issue
10
Pages
1034–1042
Identifiers
PMID: 16234051
Source
Medline
License
Unknown

Abstract

Compared with standard care, adjunctive therapy with an EGF for the management of treatment-induced anemia may increase the probability of achieving SVR, increase unadjusted lifespan, and increase quality-adjusted lifespan at an acceptable cost.

Report this publication

Statistics

Seen <100 times